Tirzepatide (40mg)

40mg Tirzepatide peptide supplied in Australia — maximum-quantity research vial for extended protocols. Dual GLP-1/GIP receptor agonist; Phase 3 trials reported up to 22.5% mean body weight reduction over 72 weeks. High-purity lyophilized powder with batch-verified CoA support and fast domestic shipping.